Overview
Michael Bar is a Hematologist Oncology specialist and a Hematologist in Stamford, Connecticut. Dr. Bar is rated as an Advanced provider by MediFind in the treatment of Atypical Hemolytic Uremic Syndrome (aHUS). His top areas of expertise are Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, and Small Lymphocytic Lymphoma (SLL).
His clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Weill Medical College Of Cornell
Jeffrey Laurence is a Hematologist Oncology specialist and a Hematologist in New York, New York. Dr. Laurence is rated as a Distinguished provider by MediFind in the treatment of Atypical Hemolytic Uremic Syndrome (aHUS). His top areas of expertise are Thrombocytopenia, Atypical Hemolytic Uremic Syndrome (aHUS), D-Minus Hemolytic Uremic Syndrome, D-Plus Hemolytic Uremic Syndrome, and Tissue Biopsy.
Weill Medical College Of Cornell
Richard Furman is a Hematologist and an Oncologist in New York, New York. Dr. Furman is rated as an Elite provider by MediFind in the treatment of Atypical Hemolytic Uremic Syndrome (aHUS). His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Richter Syndrome, Bone Marrow Aspiration, and Lymphadenectomy.
New York University
David Araten is a Hematologist Oncology specialist and a Hematologist in New York, New York. Dr. Araten is rated as a Distinguished provider by MediFind in the treatment of Atypical Hemolytic Uremic Syndrome (aHUS). His top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Aplastic Anemia, Hemolytic Anemia, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic Myelogenous Leukemia (CML)Dr. Bar isDistinguished. Learn about Chronic Myelogenous Leukemia (CML).
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Multiple MyelomaDr. Bar isDistinguished. Learn about Multiple Myeloma.
- Non-Hodgkin LymphomaDr. Bar isDistinguished. Learn about Non-Hodgkin Lymphoma.
- Philadelphia-Negative Chronic Myeloid Leukemia
- Schnitzler SyndromeDr. Bar isDistinguished. Learn about Schnitzler Syndrome.
- Advanced
- Acute Eosinophilic Pneumonia
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)
- Adult Immune Thrombocytopenia
- Antiphospholipid SyndromeDr. Bar isAdvanced. Learn about Antiphospholipid Syndrome.
- Atypical Hemolytic Uremic Syndrome (aHUS)
- Experienced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Mountain SicknessDr. Bar isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with Maturation
- Acute Promyelocytic LeukemiaDr. Bar isExperienced. Learn about Acute Promyelocytic Leukemia.
- AgranulocytosisDr. Bar isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer